DCGI

DCGI Approves Anti-COVID Drug Developed By DRDO

An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and Allied Sciences…

Read More »